Innovation Pharmaceuticals Inc (IPIX)

[makarr]

I'm admittedly a little unnerved by Dr. Jorgensen moving on to another opportunity. I've been long CTIX since 2014, so I question why would Dr. Jorgensen want to leave now, particularly with success so seemingly imminent. His expertise was brought in for Brilacidin P3, but we are yet to even initiate the trial. Even shadier to me was that they tried to sneak it in to the back end of a PR, then issued another positive but rather insignificant PR today which was a thinly veiled attempt IMO to hide the news. I still like the science, but between frivolous lawsuits, lengthy trials, staff turnover, and lack of transparency, it has been a frustrating equity to own.